Screener
Haemonetics HAE EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Haemonetics’s reported figures.
Plus components not separately reported this period.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
FAQ
- What is Haemonetics's EBIT?
- Haemonetics (HAE) reported EBIT of $57.46M in Q2 2026.
- How has Haemonetics's EBIT changed year-over-year?
- Haemonetics's EBIT increased by 6.7% year-over-year, from $53.87M to $57.46M.
- What is the long-term trend for Haemonetics's EBIT?
- Over 3 years (2022 to 2025), Haemonetics's EBIT has grown at a 40.1% compound annual growth rate (CAGR), from $80.75M to $221.82M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Haemonetics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude